NCL Technology Startup, Module Innovations raises 60 lakh in fresh funding

The Pune based startup has been developing USense, a platform based solution that detects the presence of 4 specific uropathogens during Urinary Tract Infection. The infection mostly affects women in rural settings

0
1192
Founder and CEO, Sachin Dubey (on the extreme right) with the team at Module Innovations.

Mumbai: Module Innovations, a healthcare startup based out of National Chemical Laboratory Innovation park, Pune has raised investment of Rs 50 lakh (US$ 75,000) from National Science & Technology Entrepreneurship Development Board (NSTEDB) and Rs 10 lakh (US$ 15,000)  from CIIEI, Indian Institute of Management (IIM) Ahmedabad as product development support. Module is a tech driven startup engaged in making rapid, simple, and affordable Point of care devices for microbial detection, such as in Urinary Tract Infection.

“Urinary Tract infections are the second largest infections in the world. Globally 150 million people suffer from UTI, with 1 in 3 women getting affected. With this funding we will expand the team and validate USenseTM our UTI bacteria testing technology at hospitals in Pune and Rajasthan,” said Mr Sachin Dubey, CEO, Module Innovations. “This funding would also be used to develop the platform technology for pipeline products, including CSenseTM , our urine based cervical cancer strip,” added Sachin.

Interestingly Module has raised grants from BIRAC, through BIG scheme and has also been won Starthealth-3 organized by Unitus Seed Fund. USense will help diagnose UTI causing bacteria in 30 minutes as against 2 days in culture. “USense can be used without labs and trained manpower, making it apt for rural and urban settings alike, bringing healthcare parity,” said Mr Usman Khan, COO, Module.

Currently the global diagnostic market is estimated at US$ 47 Billion.